Gwen Nichols, MD

Healio spoke with Gwen Nichols, MD, about unmet needs in CML.

Healio spoke with Gwen Nichols, MD, to discuss survivorship in CML patients.

Healio spoke with Gwen Nichols, MD, to discuss how to approach CML treatment in pediatric patients.

Healio spoke with Gwen Nichols, MD, about treatment options currently available in CML.

Healio spoke with Gwen Nichols, MD, about when to consider a CML diagnosis.

The FDA expanded the approval of bosutinib to include treatment of certain children with chronic myelogenous leukemia.

A partnership between health care systems along the U.S.-Mexico border led to clinically meaningful improvement in survival outcomes among children with acute lymphoblastic leukemia, study results showed.

Fixed-duration first-line treatment with ibrutinib plus venetoclax induced deep, durable responses among patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, according to results of the phase 2 CAPTIVATE study.

Teclistamab showed encouraging efficacy among patients with relapsed or refractory multiple myeloma, according to results of the phase 1 MajesTEC-1 study presented during the virtual ASCO Annual Meeting.

Patients with active chronic lymphocytic leukemia or multiple myeloma mounted lower antibody responses to mRNA COVID-19 vaccination than healthy individuals, according to data from two reports published in Blood.